Predicting Phenolic Acid Absorption in Caco-2 Cells: A Theoretical Permeability Model and Mechanistic Study
暂无分享,去创建一个
Gary Williamson | G. Williamson | L. Poquet | Tristan P Dew | Tracy L Farrell | Laure Poquet | Stuart Barber | T. Dew | S. Barber
[1] D. Thakker,et al. Rhodamine 123 Requires Carrier-Mediated Influx for Its Activity as a P-Glycoprotein Substrate in Caco-2 Cells , 2003, Pharmaceutical Research.
[2] Y. Kato,et al. Concentration-Dependent Effect of Naringin on Intestinal Absorption of β1-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp) , 2009, Pharmaceutical Research.
[3] A. V. Shileĭko. 1 – THEORETICAL PRINCIPLES , 1964 .
[4] G Folkers,et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] D. Barron,et al. Characterization of hydroxycinnamic acid glucuronide and sulfate conjugates by HPLC-DAD-MS(2): enhancing chromatographic quantification and application in Caco-2 cell metabolism. , 2011, Journal of pharmaceutical and biomedical analysis.
[6] Akira Yamamoto,et al. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. , 2006, International journal of pharmaceutics.
[7] D. Barron,et al. Quantitative analysis of plasma caffeic and ferulic acid equivalents by liquid chromatography tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] T. Xiang,et al. The relationship between permeant size and permeability in lipid bilayer membranes , 1993, The Journal of Membrane Biology.
[9] H vandeWaterbeemd,et al. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. , 1998 .
[10] Y. Konishi,et al. Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers. , 2004, Journal of agricultural and food chemistry.
[11] H. van de Waterbeemd. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. , 1998, European Journal of Pharmaceutical Sciences.
[12] P. Stein,et al. A Novel Method for the Investigation of Liquid/Liquid Distribution Coefficients and Interface Permeabilities Applied to the Water-Octanol-Drug System , 2011, Pharmaceutical Research.
[13] H. van de Waterbeemd,et al. ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.
[14] Gordon L. Amidon,et al. Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.
[15] S. Akanuma,et al. Lipophilicity and Transporter Influence on Blood-Retinal Barrier Permeability: A Comparison with Blood-Brain Barrier Permeability , 2010, Pharmaceutical Research.
[16] Kiyohiko Sugano,et al. Prediction of oral drug absorption in humans by theoretical passive absorption model. , 2005, International journal of pharmaceutics.
[17] Z. Wang,et al. Analysis of chlorogenic acids in beverages prepared from Chinese health foods and investigation, in vitro, of effects on glucose absorption in cultured Caco-2 cells , 2008 .
[18] C. Bernards,et al. Ascorbic Acid Inhibits Spinal Meningeal Catechol‐o‐Methyl Transferase in Vitro, Markedly Increasing Epinephrine Bioavailability , 1997, Anesthesiology.
[19] Ulf Norinder,et al. Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.
[20] M. Roller,et al. Contribution of chlorogenic acids to the inhibition of human hepatic glucose-6-phosphatase activity in vitro by Svetol, a standardized decaffeinated green coffee extract. , 2010, Journal of agricultural and food chemistry.
[21] Thomas J. Raub,et al. In vitro models for the blood-brain barrier. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.
[22] G L Amidon,et al. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. , 2000, Journal of pharmaceutical sciences.
[23] H. Waterbeemd. Improving compound quality through in vitro and in silico physicochemical profiling. , 2009 .
[24] P. Soares-da-Silva,et al. P-glycoprotein and multidrug resistance-associated protein (MRP) reverse the intestinal transport of L-DOPA, a LAT2 substrate , 2006 .
[25] W. Kirch,et al. Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans , 1996, Clinical pharmacology and therapeutics.
[26] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[27] F. Hu,et al. Coffee consumption and risk of type 2 diabetes: a systematic review. , 2005, JAMA.
[28] Li Di,et al. Coexistence of passive and carrier-mediated processes in drug transport , 2010, Nature Reviews Drug Discovery.
[29] Barry Press,et al. Permeability for intestinal absorption: Caco-2 assay and related issues. , 2008, Current drug metabolism.
[30] H. Corti,et al. Octanol-water partition coefficient of glucose, sucrose, and trehalose. , 2005, Carbohydrate research.
[31] P. Artursson,et al. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.
[32] Bernard Testa,et al. Lipophilicity and Its Relationship with Passive Drug Permeation , 2011, Pharmaceutical Research.
[33] G. Williamson,et al. Transport and Metabolism of Ferulic Acid through the Colonic Epithelium , 2008, Drug Metabolism and Disposition.
[34] H. Lennernäs,et al. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo , 1996 .
[35] C. Bernards,et al. Physical and chemical properties of drug molecules governing their diffusion through the spinal meninges. , 1992, Anesthesiology.
[36] Alex Avdeef,et al. How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? , 2010, Journal of medicinal chemistry.
[37] Kristina Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .
[38] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.
[39] J. Alsenz,et al. Development of a 7-Day, 96-Well Caco-2 Permeability Assay with High-Throughput Direct UV Compound Analysis , 2003, Pharmaceutical Research.
[40] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[41] W. Higuchi,et al. In vitro model for transport of solutes in three-phase system. I. Theoretical principles. , 1972, Journal of pharmaceutical sciences.
[42] M. Kataoka,et al. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[43] M. Yazdanian,et al. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.
[44] W I Higuchi,et al. In vitro model for transport of solutes in three-phase system. II. Experimental considerations. , 1972, Journal of pharmaceutical sciences.